Literature DB >> 7836460

Crystal structure of the OPG2 Fab. An antireceptor antibody that mimics an RGD cell adhesion site.

R Kodandapani1, B Veerapandian, T J Kunicki, K R Ely.   

Abstract

Cell surface receptors called integrins mediate diverse cell adhesion phenomena through recognition of the sequence arginine-glycine-aspartic acid (RGD) present in proteins such as fibronectin and fibrinogen. Platelet aggregation in hemostasis is mediated by the binding of fibrinogen to the gpIIb/IIIa integrin. The OPG2 antibody binds the gpIIb/IIIa receptor and acts as a ligand mimic due to the presence of an arginine-tyrosine-aspartic acid (RYD) sequence in the CDR3 loop of the heavy chain. The RYD loop and side chains are ordered in the 2.0-A resolution crystal structure of the Fab fragment from this antireceptor antibody. Moreover, the RYD loop assumes two clearly defined conformations that may correspond to the orientations of the loop in the free state or bound to integrin. This molecule will serve as a tool for understanding protein-integrin recognition in platelet aggregation and other RGD-mediated cell adhesion interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7836460     DOI: 10.1074/jbc.270.5.2268

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  A residue-specific shift in stability and amyloidogenicity of antibody variable domains.

Authors:  Cardine N Nokwe; Martin Zacharias; Hisashi Yagi; Manuel Hora; Bernd Reif; Yuji Goto; Johannes Buchner
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

2.  A two-amino acid insertion in the Cys146- Cys167 loop of the alphaIIb subunit is associated with a variant of Glanzmann thrombasthenia. Critical role of Asp163 in ligand binding.

Authors:  S Honda; Y Tomiyama; M Shiraga; S Tadokoro; J Takamatsu; H Saito; Y Kurata; Y Matsuzawa
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

3.  Dynamic regulation of fibrinogen: integrin αIIbβ3 binding.

Authors:  Roy R Hantgan; Mary C Stahle; Susan T Lord
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

4.  Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain.

Authors:  R C Fisher; M C Olson; J M Pongubala; J M Perkel; M L Atchison; E W Scott; M C Simon
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

5.  An autonomous CDR3delta is sufficient for recognition of the nonclassical MHC class I molecules T10 and T22 by gammadelta T cells.

Authors:  Erin J Adams; Pavel Strop; Sunny Shin; Yueh-Hsiu Chien; K Christopher Garcia
Journal:  Nat Immunol       Date:  2008-05-30       Impact factor: 25.606

6.  Peptide-based delivery vectors with pre-defined geometrical locks.

Authors:  Ruchika Goyal; Gaurav Jerath; Aneesh Chandrasekharan; T R Santhosh Kumar; Vibin Ramakrishnan
Journal:  RSC Med Chem       Date:  2020-08-13

7.  SCMTHP: A New Approach for Identifying and Characterizing of Tumor-Homing Peptides Using Estimated Propensity Scores of Amino Acids.

Authors:  Phasit Charoenkwan; Wararat Chiangjong; Chanin Nantasenamat; Mohammad Ali Moni; Pietro Lio'; Balachandran Manavalan; Watshara Shoombuatong
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.